Intuitive Surgical (NASDAQ: ISRG) makes the da Vinci surgical robot.
It is a leader in the surgical robotics niche of the broader healthcare sector
The company has been growing rapidly, with its installed base of robots increasing 12% in 2025, to 11,106 systems. The installed base grew to 11,395 in the first quarter of 2026. Wall Street has rewarded the medical device company for its growth, with the stock up over 400% over the past decade.
However, it goes through frequent and deep drawdowns, which could be an opportunity for investors right now. Intuitive Surgical is building a cash-flow machine The big story with Intuitive Surgical isn’t actually da Vinci robot sales. That segment of the business only accounts for around 25% of the top line.